Israel scientists cure all COVID patients with new therapy!

on . Posted in Articles of Interest

JERUSALEM, Israel (PNN) - February 17, 2021 - Israeli scientists have developed a promising new immune therapy that cured 100% of COVID patients in three to five days. The therapy helps mitigate the cytokine storm that is sometimes observed in COVID patients. The Tel Aviv Sourasky Medical Center has developed a drug called EXO-CD24, which functions as an experimental inhaled medication. In the Phase 1 clinical trial, the medication cured all thirty cases of moderate to severe COVID-19 infection. The medication is inhaled for a few minutes, once a day, for five days.

The immune therapy mitigates the overproduction of cytokines, restoring inter-cellular communication, and helping the person’s immune system detect and combat replicating viruses. Because it is delivered precisely to the lungs, there are no systemic side effects, as often observed with oral or injected drugs.

Around 5-7% of COVID patients suffer from a cytokine storm. This is when the immune system overreacts and starts attacking healthy cells in the lungs. The inhaled medication uses exosomes (vesicles) that are typically released from cell membranes. These exosomes are released for the purpose of inter-cellular communication. The medication enriches the exosomes with 24CD protein. In a healthy immune system, this protein is expressed on the surface of the cell and helps regulate the immune system. The medication supplies the lungs with this critical protein for inter-cellular communication, to help modulate a healthy immune response. The people who experience complications from respiratory infection are lacking critical surface surveillance proteins that help the immune system communicate and detect viral threats.

The hospital in charge of the study reports, “To date, the preparation has been tried with great success on 30 severe patients, in 29 of whom the medical condition improved within two to three days. and most of them were discharged home within three to five days. The 30th patient also recovered but after a longer time.”

The drug can be produced very quickly and distributed at a very low cost to hospitals and pharmacies around the world. “Even if the vaccines perform their function, and even if no new mutations are produced then still in one way or another the corona will remain with us,” said Prof. Nadir Arber, director of the medical center’s Integrated Cancer Prevention Center. “To this end, we have developed a unique drug, EXO-CD24.” The research is built upon the work of Dr. Shiran Shapira, who has been researching the CD24 protein for over two decades.

Finding the underlying causes of damaged immune systems is key to overcoming infectious disease

No matter the level of masking, no matter how many vaccines are pumped into people’s arms; populations continue to suffer from respiratory illness, whether it’s COVID-19, pneumonia, one of many hospital-acquired infections, or any other influenza mutation or coronavirus variant. The demand for antiviral drugs and immune therapy is high, and will remain high well into the future as malnourished, over-vaccinated populations seek medical help for their autoimmune issues, inflammatory conditions, strained lungs, and compromised cellular terrain.

Another protein that is an important facet of the human immune system is mannose binding lectins (MBLs). A subset of human populations is born deficient in MBLs, a surface surveillance protein that helps the immune system detect invading pathogens. MBLs are unique because they can bind to the surface of microbes and activate the complement system in an antibody. Deficiency in MBLs occurs when there is a three single point mutation in exon 1 of the MBL-2 gene. MBLs bind with sugars including N-acetyl-D-glucosamine, mannose, N-acetyl-mannosamine, fucose and glucose.

This sugar-binding process allows the protein to interact with many different kinds of viruses, bacteria, yeasts, fungi and protozoa cloaked with such sugars. Deficiency in MBLs is linked to chronic obstructive pulmonary disease and complications from respiratory syncytial virus (RSV), and other respiratory distress. Oxidative stress decreases functional airway mannose binding lectin in COPD. Mitigating oxidative stress is also important for healthy function of lung cells and surface proteins. In short, the surface surveillance proteins are an important factor in how people recover from infectious disease. Finding the underlying causes of damaged immune systems is key to overcoming infectious disease.

Eulogies

Eulogy for an Angel
1992-Dec. 20, 2005

Freedom
2003-2018

Freedom sm

My Father
1918-2010

brents dad

Dr. Stan Dale
1929-2007

stan dale

A. Solzhenitsyn
1918-2008

solzhenitsyn

Patrick McGoohan
1928-2009

mcgoohan

Joseph A. Stack
1956-2010

Bill Walsh
1931-2007

Walter Cronkite
1916-2009

Eustace Mullins
1923-2010

Paul Harvey
1918-2009

Don Harkins
1963-2009

Joan Veon
1949-2010

David Nolan
1943-2010

Derry Brownfield
1932-2011

Leroy Schweitzer
1938-2011

Vaclav Havel
1936-2011

Andrew Breitbart
1969-2012

Dick Clark
1929-2012

Bob Chapman
1935-2012

Ray Bradbury
1920-2012

Tommy Cryer
1949-2012

Andy Griffith
1926-2012

Phyllis Diller
1917-2012

Larry Dever
1926-2012

Brian J. Chapman
1975-2012

Annette Funnicello
1942-2012

Margaret Thatcher
1925-2012

Richie Havens
1941-2013

Jack McLamb
1944-2014

James Traficant
1941-2014

jim traficant

Dr. Stan Monteith
1929-2014

stan montieth

Leonard Nimoy
1931-2015

Leonard Nimoy

Stan Solomon
1944-2015

Stan Solomon

B. B. King
1926-2015

BB King

Irwin Schiff
1928-2015

Irwin Schiff

DAVID BOWIE
1947-2016

David Bowie

Muhammad Ali
1942-2016

Muhammed Ali

GENE WILDER
1933-2016

gene wilder

phyllis schlafly
1924-2016

phylis schafly

John Glenn
1921-2016

John Glenn

Charles Weisman
1954-2016

Charles Weisman

Carrie Fisher
1956-2016

Carrie Fisher

Debbie Reynolds
1932-2016

Debbie Reynolds

Roger Moore
1917-2017

Roger Moore

Adam West
1928-2017

Adam West

JERRY LEWIS
1926-2017

jerry lewis

HUGH HEFNER
1926-2017

Hugh Hefner

PROF. STEPHEN HAWKING
1942-2018

Hugh Hefner 

ART BELL
1945-2018

Art Bell

DWIGHT CLARK
1947-2018

dwight clark

CARL MILLER
1952-2017

Carl Miller

HARLAN ELLISON
1934-2018

Harlan Ellison

STAN LEE
1922-2018

stan lee

CARL REINER
1922-2020

Carl Reiner

SEAN CONNERY
1930-2020

dwight clark